EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Incremental Prognostic Value of the Haemoglobin-Albumin-Lymphocyte-Platelet Score and B-Type Natriuretic Peptide for 30-Day Mortality After Elective On-Pump Coronary Artery Bypass Grafting

Hafize Yalınız iD, Onur Benli iD

Interdisciplinary CardioVascular and Thoracic Surgery · 01.07.2026 · 41 (7)

DOI: 10.1093/icvts/ivag190 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Interdisciplinary CardioVascular and Thoracic Surgery, online erschienen am 30.06.2026. Verfasst von Hafize Yalınız und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, Cukurova University Faculty of Medicine, 01433 Adana, Turkey. Hauptthemen laut MEDLINE: Natriuretic Peptide, Brain, Coronary Artery Bypass, Hemoglobins, Coronary Artery Disease. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study evaluated whether preoperative haemoglobin-albumin-lymphocyte-platelet (HALP) score and B-type natriuretic peptide (BNP) were associated with 30-day mortality after elective on-pump coronary artery bypass grafting (CABG) and whether they improved prognostic assessment beyond European System for Cardiac Operative Risk Evaluation II (EuroSCORE II).

Methods

Among 492 eligible patients, 466 with complete data on 30-day mortality and the prespecified primary predictors constituted the primary analytic cohort. Associations were examined using Firth penalized logistic regression, and internal validation was performed with bootstrap resampling.

Results

Twenty-one patients (4.5%) died within 30 days. Lower HALP and higher BNP were independently associated with mortality after adjustment for EuroSCORE II. The optimism-corrected area under the curve improved from 0.879 for EuroSCORE II alone to 0.974 after the addition of HALP and to 0.979 after further addition of BNP.

Conclusions

Lower HALP and higher BNP were associated with 30-day mortality after elective on-pump CABG and may provide incremental prognostic information beyond EuroSCORE II. These findings should be considered exploratory.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Natriuretic Peptide, BrainCoronary Artery BypassHemoglobinsCoronary Artery DiseaseBlood PlateletsLymphocytesHumansMaleFemaleAgedBiomarkersElective Surgical ProceduresPredictive Value of TestsRisk FactorsMiddle AgedRisk AssessmentPlatelet CountTime FactorsTreatment OutcomeLymphocyte CountRetrospective Studies

Stichwörter der Autor:innen

EuroSCORE IIbiomarkerscoronary artery bypass graftinginflammation

Substanzen

Natriuretic Peptide, BrainHemoglobinsBiomarkers

Autor:innen und Institutionen

  • Department of Cardiovascular Surgery, Cukurova University Faculty of Medicine, 01433 Adana, Turkey.

ORCID-Profile: Hafize Yalınız, Onur Benli

Zitieren

APA

Yalınız, H., & Benli, O. (2026). Incremental Prognostic Value of the Haemoglobin-Albumin-Lymphocyte-Platelet Score and B-Type Natriuretic Peptide for 30-Day Mortality After Elective On-Pump Coronary Artery Bypass Grafting. Interdisciplinary CardioVascular and Thoracic Surgery, 41(7). https://doi.org/10.1093/icvts/ivag190

Vancouver

Yalınız H, Benli O. Incremental Prognostic Value of the Haemoglobin-Albumin-Lymphocyte-Platelet Score and B-Type Natriuretic Peptide for 30-Day Mortality After Elective On-Pump Coronary Artery Bypass Grafting. Interdisciplinary CardioVascular and Thoracic Surgery. 2026;41(7). doi:10.1093/icvts/ivag190

BibTeX
@article{Yalnz2026,
  author = {Yalınız, Hafize and Benli, Onur},
  title = {Incremental Prognostic Value of the Haemoglobin-Albumin-Lymphocyte-Platelet Score and B-Type Natriuretic Peptide for 30-Day Mortality After Elective On-Pump Coronary Artery Bypass Grafting},
  journal = {Interdisciplinary CardioVascular and Thoracic Surgery},
  year = {2026},
  volume = {41},
  number = {7},
  doi = {10.1093/icvts/ivag190}
}
Kostenlos starten →